The American Society of Clinical Oncology, or ASCO, is holding the society's 51st annual meeting from May 29 to June 2 in Chicago, Illinois.
Shares of Synta Pharmaceuticals (SNTA) were up Thursday after the company announced presentations at the upcoming annual meeting of the American Association of Cancer Research.
Shares of Synta Pharmaceuticals (SNTA) hit a one-year low on Tuesday after the biopharmaceutical company announced the pricing of an underwritten public offering of common stock.
Investors in Synta Pharmaceuticals Corp saw new options become available this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SNTA options chain for the new March 20th contracts and identified the following call contract of particular interest.